Topic: medicare coverage

Trump's GLP-1 Deal Sparks Questions Over Drug Pricing

The White House announced new agreements with Novo Nordisk and Eli Lilly to reduce prices of GLP-1 medications like Ozempic and Wegovy to $245 per month for certain Medicare and Medicaid recipients. The discounted pricing applies only to a limited group of patients who meet specific clinical crit...